Correlation Between Neurocrine Biosciences and Tilray

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Tilray at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Tilray into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Tilray Inc, you can compare the effects of market volatilities on Neurocrine Biosciences and Tilray and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Tilray. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Tilray.

Diversification Opportunities for Neurocrine Biosciences and Tilray

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Neurocrine and Tilray is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Tilray Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tilray Inc and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Tilray. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tilray Inc has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Tilray go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Tilray

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.53 times more return on investment than Tilray. However, Neurocrine Biosciences is 1.9 times less risky than Tilray. It trades about 0.02 of its potential returns per unit of risk. Tilray Inc is currently generating about -0.09 per unit of risk. If you would invest  12,510  in Neurocrine Biosciences on August 31, 2024 and sell it today you would earn a total of  149.00  from holding Neurocrine Biosciences or generate 1.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neurocrine Biosciences  vs.  Tilray Inc

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong forward indicators, Neurocrine Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Tilray Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tilray Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Neurocrine Biosciences and Tilray Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and Tilray

The main advantage of trading using opposite Neurocrine Biosciences and Tilray positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Tilray can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tilray will offset losses from the drop in Tilray's long position.
The idea behind Neurocrine Biosciences and Tilray Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance